|
Keeping up with the Chemos Series: Mirvetuximab Soravtansine - Administration (Part 2) |
|
Enduring |
|
$0.00 |
|
Keeping up with the Chemos Series: Mirvetuximab Soravtansine - Follow up Monitoring Between Cycles (Part 3) |
|
Enduring |
|
$0.00 |
|
Chemotherapy & Targeted Therapies Flash Cards |
|
Enduring |
|
$0.00 |
|
Gestational Trophoblastic Neoplasia (GTN) Education Module |
|
Enduring |
|
$15.00 |
|
On-Demand Webinar: Optimizing Gynecologic Cancer Care in an Era of Chemotherapy Drug Shortages: SGO Updates and Recommendations |
|
Enduring |
|
$35.00 |
|
On-Demand Webinar: Chemotherapy Shortages: Root Causes, Regulatory Landscape, Legislative Process, and How the SGO is Navigating the Present and... |
|
Enduring |
|
$35.00 |
|
Scientific Plenary III: Farr Nezhat Surgical Innovation Session |
|
Enduring |
|
$0.00 |
|
Focused Plenary IV: Leave No Patient Behind: Progress Towards Equity |
|
Enduring |
|
$0.00 |
|
Focused Plenary I: It's Getting Hot in Here... (HIPEC) |
|
Enduring |
|
$0.00 |
|
Highlights from the 2023 Annual Meeting on Women's Cancer |
|
Enduring |
|
$195.00 |
|
Education Forum II: New Drugs, New Problems: Managing Toxicities |
|
Enduring |
|
$0.00 |
|
Focused Plenary II: Circulating DNA Tumor: It's In Your Blood |
|
Enduring |
|
$0.00 |
|
Scientific Plenary IV: This Just In! Late Breaking Abstracts |
|
Enduring |
|
$0.00 |
|
2023 Annual Meeting Surgical Films |
|
Enduring |
|
$50.00 |
|
The Future is Now: Determining the Fate of Gynecologic Oncology |
|
Enduring |
|
$0.00 |
Facebook
Twitter
LinkedIn
Forward